Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 57 publications.

Hu A, Kwon M, Chung L, Rastegar J, Stevens L, Schwab P. HIV prep adherence on incidence of HIV diagnosis in a national health plan population. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Alpert C, Rhodes C, Stevens L, Ellis JJ, Johnson S, Schwab P. Evaluation of pharmacist-led interventions for patients flagged for high morphine milligram equivalents (MME). Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S93.

Patel SM, Schwab P, Garcia B, Ellis JJ, Vaccaro J. Description of vaccination status and incidence of shingles. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Huang I, Schwab P, Wojcicki S, Poonawalla I, Ellis JJ, Racsa P. Febrile neutropenia risk and health care costs in members receiving low-risk antineoplastic regimens with and without granulocyte colony stimulating factor primary prophylaxis support. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Sanders C, Schwab P, Poonawalla I, Grebe L, Sassack K, Kennedy K, Vaccaro J, Ellis J. A real-world characterization of adverse drug events of Bruton tyrosine kinase inhibitors. Poster presented at the 2021 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 13, 2022. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a).

Klepitskaya O, Serbin M, Sutphin J, Leach C, Mansfield C, Yonan C, Sheehan M, Donnelly A. Development of a patient survey on preferences for adjunctive parkinson's disease medications: results from pretest interviews. Poster presented at the AMCP Nexus 2021; October 18, 2021. [abstract] J Manag Care Pharm. 2021 Oct; 27(10-a):S8.

Xiao H, Blum S, Davenport E, Wang J, Hunter S, Li M, Kondo K. Health care resource utilization of patients with advanced gastric cancer/gastroesophageal junction cancer or esophageal adenocarcinoma: results of nivolumab plus chemotherapy versus chemotherapy from CheckMate 649. Poster presented at the AMCP Nexus 2021; October 18, 2021. [abstract] J Manag Care Pharm. 2021 Oct; 27(10-a):S19.

Gold BD, Goodwin B, Davis K, Sweeney C, Reynolds M, Jiang J, Fan T, Boules M, Desai NK, Katzka DA. Treatment burden and associated costs in adolescents and adults with eosinophilic esophagitis in the USA. Poster presented at the AMCP Nexus 2021; October 19, 2021. [abstract] J Manag Care Pharm. 2021 Oct; 27(10-a):S82.

Appukkuttan S, Farej R, Miles L, Purser M, Wen L. Budget-impact of adding darolutamide to a United States payer formulary for non-metastatic castration-resistant prostate cancer. Poster presented at the 2020 AMCP (Conference cancelled); April 21, 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr 20; 26(4-a):S18.

Aggarwal K, Vredenburg M, Mladsi D, Barnett C. Cost-effectiveness of avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Poster presented at the 2020 AMCP Meeting (Conference cancelled); April 2020. [abstract] J Manag Care Pharm. 2020 Apr; 26(Supplement 4a):s58.

Obimah A, Goyal RK, Bhansali A, Sansgiry SS. Can intervention tools with better message framing lead to better intention: a case of chemoprevention for breast cancer. Poster presented at the 2020 AMCP (Conference cancelled); April 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr; 26(4-a):S89.

Parikh R, Niyazov A, Esterberg E, Arondekar B, Arruda L, Obeid E. Real-World treatment patterns and safety outcomes among patients with HER2 negative advanced breast cancer and BRCA1/2 mutations: evidence from a retrospective medical record review study in the United States. Poster presented at the 2020 AMCP (Conference cancelled); April 21, 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr; 26(4-a):S16.

Thach A, Sutphin J, Coulter J, Mansfield C. Patient experiences and preferences for specific on-demand treatments for Parkinson's Disease-related “OFF” episodes. Poster presented at the 2020 AMCP (Conference cancelled); April 21, 2020. Houston, TX. [abstract] J Manag Care Pharm. 2020 Apr; 26(4-a):S40.

Horter L, Dickinson E, Harvey R, Schwab P, Ward M, Sehman M. Treatment patterns in new user cohorts of non-specialty first-line therapy for immune-mediated inflammatory diseases. Poster presented at the 2019 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 25, 2019. San Diego, CA. [abstract] J Manag Care Pharm. 2019 Mar; 25(3-a):S81.

DiBenedetti D, Tzivelekis S, Meckley L. Humanistic cost impacts associated with immunoglobulin replacement therapy among patients with primary immunodeficiency disease in the United States. Poster presented at the 2019 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 25, 2019. San Diego, CA. [abstract] J Manag Care Pharm. 2019 Mar; 25(3-a Suppl):S37.

Yun S, Schwab P, Piazza B, Dickinson E. Exploration of proportion of days covered thresholds for medical cost offset /outcomes among patients using inhaled therapies for moderate to severe chronic obstructive pulmonary disease. Poster presented at the 2019 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 25, 2019. [abstract] J Manag Care Pharm. 2019 Mar; 25(3-a):S11.

Bugner C, Vaccaro J, Schwab P, Cornett D, Drzayich Jankus D, Martinez Vasquez D, Harris J, Sethi M, Cole B. Real-world comparative effectiveness, safety, and health care costs of Sacubitril/ Valsartan versus Angiotensin-II receptor blockers in a Medicare population. Poster presented at the 2019 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 25, 2019. [abstract] J Manag Care Pharm. 2019 Mar; 25(3-a):S10.

Nag A, Olayinka-Amao B, Martin S, Purser M, Mladsi D. The humanistic burden of chronic idiopathic constipation in the US: a systematic review. Poster presented at the 2019 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 25, 2019. San Diego, CA. [abstract] J Manag Care Pharm. 2019 Mar; 25(3-a Suppl):S17.

Carrico J, Zhao Y, Jia X, Brodtkorb TH, Mendelsohn A, Lowry S. Budget impact of introducing tildrakizumab for the treatment of moderate to severe plaque psoriasis in the United States. Poster presented at the 2018 AMCP NEXUS; October 24, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10-a):s78.

Nagar SP, Fan Y, Meyers J, Tighe RM. Real-world treatment patterns of nintedanib among patients with idiopathic pulmonary fibrosis in the United States. Poster presented at the 2018 AMCP NEXUS; October 24, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10-a):S71.

Jia X, Zhao Y, Carrico J, Brodtkorb TH, Mendelsohn A, Lowry S, Feldman S, Wu JJ, Armstrong A. Cost-effectiveness analysis of tildrakizumab in patients with moderate to severe plaque psoriasis in the United States. Poster presented at the 2018 AMCP NEXUS; October 24, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10-a):S78.

Jia X, Zhao Y, Carrico J, Brodtkorb TH, Mendelsohn A, Lowry S, Feldman S, Armstrong A, Wu JJ. Comparative cost per time in response for tildrakizumab and other targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis in the United States. Poster presented at the 2018 AMCP NEXUS; October 22, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10a):S79.

Parikh R, Clancy Z, Candrilli S, Parikh K. Administrative data algorithms to identify diagnosis and treatment-related measures in patients with multiple myeloma: a validation study. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 25, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-2):S29.

Chiang J, Schwab P, McCulloch R, Brooks P, Rhodes C, Happe L. Impact of a retrospective drug utilization review program on changing opioid prescribing behavior. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S11.

Graham C, McGuire M, Knox H, Ung B. Budget impact analysis of enasidenib treatment in patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S31.

Krishnarajah G, Knox H, Graham CN, Christiansen S, Zuraw B. Subcutaneous C1-inhibitor prophylactic treatment for hereditary angioedema: a budget impact model. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 23, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S37.

Patterson B, Curran D, Buck P, Varghese L, Oorschot D, Carrico J, Hicks K, Lee B, Yawn B. Cost-effectiveness of candidate adjuvanted subunit vaccine for vaccinating U.S. adults not previously vaccinated against herpes zoster. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 25, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S20.

Buck PO, Curran D, Patterson BJ, Varghese L, van Oorschot D, Carrico J, Hicks K, Lee BY, Yawn BP. Cost-effectiveness of adjuvanted recombinant zoster vaccine (RZV) for vaccinating US adults not previously vaccinated against herpes zoster. Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 25, 2018. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S20.

Bhattacharya R, Herren K, Poonwalla I, Bunniran S, Bloomfield A, Schwab P. Comparative effectiveness study among naive users of injectable versus oral biologic immunotherapies. Presented at the 2018 AMCP Annual Meeting; April 26, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S17.

Mansfield C, Gebben D, Sutphin J, Tepper SJ, Schwedt TJ, Sapra S, Shah N. Patient preferences for preventive migraine treatments: a discrete-choice experiment. Poster presented at the 2017 AMCP NEXUS; October 18, 2017. Dallas, TX. [abstract] J Manag Care Pharm. 2017 Oct; 23(10-a):S55.

Swanger C, Tobbe C, Schwab PE, Lane D, Hurwitch A. Opioid utilization patterns in a humana commercial and medicare population. Poster presented at the 2016 Academy of Managed Care Pharmacy's 28th Annual Meeting & Expo; October 3, 2016. National Harbor, MD. [abstract] J Manag Care Pharm. 2016 Oct; 22(10-a).

Willson T, Montejano L, Wollschlaeger B, Ronquest N, Nadipelli V. Real-world dosing patterns among patients receiving buprenorphine for opioid dependence in the United States. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S60.

Hogue SL, Silvia S, Hollis K, Goss D, Odom D, Cooney D, White MV. EPIPEN4SCHOOLS® survey combined analysis: staff training and use of epinephrine auto-injectors. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 19, 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S116. Previously presented at the 2016 ACAAI Conference.

Graham J, Xuan D, Luthra R, Borker R, Earnshaw SE, Lim J. Budget impact analysis of afatinib for the first-line treatment of metastatic non-small cell lung cancer patients with epidermal growth factor receptor exon 19 deletion mutations in a U.S. health plan. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S30.

Dhamane A, Candrilli S, Meyers J, Luthra R, Kaila S. Initial diagnosis and treatment patterns by healthcare setting among chronic obstructive pulmonary disease (COPD) patients in the United States. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S90.

Mansfield C, Thomas N, Gebben D, Lucas M, Hauber B. Differences in preferences for disease-modifying treatments across subgroups of U.S. patients with relapsing multiple sclerosis. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 19, 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S66.

Tam I, Candrilli S, Moss J. Health care resource utilization associated with tympanostomy tube placement in pediatric populations. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S80.

Waters H, Goyal R, Strouss L, Legacy S, Nagar S, Wilbanks J. Regional differences in HEDIS measure results for schizophrenia treatment adherence in state Medicaid programs. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 19, 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S62.

Stanford RH, Nagar S, Lin X, O'Connor RD. Use of ICS/LABA on asthma exacerbation risk in patients within a medical group. J Manag Care Pharm. 2015 Nov;21(11):1014-9.

Hogue S, Hollis K, Silvia S, Wooddell M, White MV. Staff training and use of epinephrine auto-injectors for the treatment of anaphylaxis: results from the EPIPEN4SCHOOLS survey. Poster presented at the 2015 AMCP Nexus; October 27, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10a):s7.

Mladsi D, Ramamohan V, Ronquest N, Boklage SH. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among SIADH patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S33.

Ramamohan V, Mladsi D, Ronquest N, Boklage S. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among CHF patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S53.

Dalal AA, Patel JP, D'Souza A, Farrelly E, Nagar S, Shah M. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Pharm. 2015 Jul;21(7):575-83.

Korsnes JS, Davis KL, Ariely R, Bell C, Mitra D. Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events. J Manag Care Pharm. 2015 Jun;21(6):443-50.

DaCosta Byfield S, McPheeters JT, Burton T, Nagar SP, Hackshaw MD. Persistence and compliance among US patients receiving pazopanib or sunitinib as first-line therapy for advanced renal cell carcinoma. J Manag Care Pharm. 2015 Jun;21(6):515-22.

Maglinte G, Graham C, Schwartzberg L, Price T, Knox H, Hechmati G, Hjelmgren J, Barber B, Fakih M. Economic analysis of panitumumab versus cetuximab in chemorefractory patients with wild-type KRAS metastatic colorectal cancer. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 9, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 21(4a):S11-2.

Wilson M, Mody R, Ursan I, Carr S. The budgetary impact of vedolizumab in the management of moderately to severely active ulcerative colitis and Crohn's disease in the United States. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 7, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 21(4a):S57.

Patel J, Coleman A, Wilson M, McDade C, Carr S, Earnshaw S. Budgetary impact on a U.S. health plan after adopting umeclidinium/vilanterol (UMEC/VI) for the management of moderate-to-severe COPD. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 7, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr 7; 21(4a):S55.

Kamble P, Walker D, Marx S, Uribe C, Bunniran S, Collins J. Real-world medication adherence in hepatitis C patients on recently approved direct-acting antivirals. Poster presented at the 2015 AMCP's 27th Annual Meeting & Expo; April 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr; 21(4-2):S5.

Wang T, Meyers J, Davis K, Madhwani S, Boklage S. Patterns of H. pylori treatment and testing for patients in a commercially insured population. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 1, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr; 21(4-a):S11.